Top Markets
Coin of the day
China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd.

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

300294
Rang in Aktien #9112
Established in 1993 and headquartered in Fuzhou, China, China Resources Boya... Established in 1993 and headquartered in Fuzhou, China, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (formerly Boya Bio-pharmaceutical Group Co., Ltd.) is a comprehensive pharmaceutical enterprise operating across China. The company is engaged in the research, development, production, and sale of a diverse portfolio, primarily focusing on blood products, diabetes medications, and various biochemical and chemical pharmaceuticals. Its extensive range of blood-derived products includes human fibrinogen, human albumin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, and freeze-dried intravenous human immunoglobulin. For diabetes management, the company offers metformin hydrochloride (both tablets and enteric-coated versions), pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules. Additionally, it produces specialized injections such as compound osteotide, oxytocin, and heparin sodium, which are utilized across numerous medical fields, including general medicine, hepatitis treatment, gynecology, and immunomodulatory applications.
Aktienkurs
$2.16
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$1.09B
Veränderung (1 Tag)
-0.07%
Veränderung (1 Jahr)
-42.06%
Land
CN
Handel China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)

Kategorie

Kursverlauf für China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)
Höchster Schlusskurs: $2.22 am 2026-08-01

Niedrigster Schlusskurs: $1.36 am 2012-03-01
Kursverlauf der Aktie von China Resources Boya Bio-pharmaceutical Group Co., Ltd. von 2012 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -11.03%
2025 -22.56%
2024 -11.80%
2023 -2.68%
2022 -17.73%
2021 8.25%
2020 24.02%
2019 5.57%
2018 -8.13%
2017 -16.39%
2016 34.70%
2015 68.02%
2014 43.01%
2013 67.86%
2012 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH